Amid a surge in drug-resistant bacteria, researchers believe they have discovered a new class of antibiotics, three decades ...

Lariocidin was efficient against strains of E. coli, including drug-resistant ones, according to the new study. View on ...

The last time a new class of antibiotics reached the market was nearly three decades ago—but that could soon change, thanks ...

The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the ...

There are also antibiotics such as ciprofloxacin ... More information: Developing an Ecotoxicological Classification for Frequently Used Drugs in Primary Care, International Journal of ...

That process led to the group discovering a lasso peptide that exhibited broad-spectrum antibiotic activity and was effective ...

If you deal with recurrent UTIs, a new FDA-approved antibiotic called Blujepa could offer another treatment option—especially ...

Researchers discover a new class of antibiotic that selectively targets Neisseria gonorrhoeae, the bacterium that causes gonorrhoea. These substances trigger a self-destruction program, which also ...

Researchers discovered lariocidin, a lasso peptide antibiotic that kills multidrug-resistant bacteria by binding a novel ...

They found a new molecule named lariocidin —a potential new antibiotic with the power to kill some of the world’s most ...

Painkillers and antibiotics among the most problematic ... Journal of Environmental Research and Public Health, 2025 Drug classification*, overview of results: *The word “drug” is used here ...

Researchers say they have discovered a new class of antibiotics that could treat drug-resistant bacteria, the first to reach the market in nearly three decades. The new molecule, called ...